Our business is built on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way.
Our key contribution is to discover and develop innovative medicines and make them accessible to patients throughout the world. But we know that to support better diabetes health for generations to come, we must also invest in efforts to prevent type 2 diabetes and obesity, educating healthcare professionals, offering patient support programmes, and ensuring that we have no negative impact on people, communities and the environment.
Tens of millions of people living with diabetes cannot get access to the life-saving insulin and the medical care they need.
We are committed to doing our part to ensure that no one should go without access to medicine and treatment.
We are transitioning from a linear economy of 'take-make-dispose' to a circular economy based on three principles: Design out waste and pollution, keep products and materials in use, and regenerate natural systems.
The huge rise in type 2 diabetes around the world is catastrophic. One in nine adults are projected to have the disease by 2045. This would devastate people’s lives and risks crippling health systems.
Uncontrolled, this rise is not sustainable for anyone – people, health systems, businesses or economies. Bending the curve on diabetes is therefore crucial to all of us.
We remain committed to the principles of responsible business conduct promoted by the United Nations Global Compact.
Read our Communication on Progress